We are live on ! Find out more
SRTA

Strata Critical Medical Inc

117 hedge funds and large institutions have $135M invested in Strata Critical Medical Inc in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $557K | Put options by funds: $431K

26% more capital invested

Capital invested by funds: $107M → $135M (+$28.2M)

24% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 33

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

3% more funds holding

Funds holding: 114117 (+3)

0.49% more ownership

Funds ownership: 49.69%50.18% (+0.49%)

Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
41
Reduced
33
Closed
18
Calls
$557K
Puts
$431K
Net Calls
+$126K
Net Calls Change
-$31K
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$22.4M +$768K +230,216 +4%
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$14.1M +$1.27M +381,308 +10%
NAMA
3
Nikko Asset Management Americas
New York
$14M +$1.2M +358,539 +10%
BlackRock
4
BlackRock
New York
$13.6M -$415K -124,556 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.2M -$131K -39,402 -1%
AIC
6
AWM Investment Company
New York
$9.02M +$1.52M +454,736 +21%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$4.6M +$120K +36,064 +3%
State Street
8
State Street
Massachusetts
$4.35M +$254K +76,071 +6%
NRCM
9
Northern Right Capital Management
Connecticut
$4.02M -$148K -44,268 -4%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$3.26M +$606K +181,630 +24%
JP Morgan Chase
11
JP Morgan Chase
New York
$3.19M +$125K +37,567 +4%
UIC
12
Uniplan Investment Counsel
Wisconsin
$2.94M -$2.21M -662,990 -44%
RJA
13
Raymond James & Associates
Florida
$2.28M +$124K +37,243 +6%
TI
14
Tidal Investments
Wisconsin
$1.98M -$120K -35,898 -6%
AQR Capital Management
15
AQR Capital Management
Connecticut
$1.9M +$543K +162,867 +42%
BGIM
16
Brandywine Global Investment Management
Pennsylvania
$1.79M +$224K +67,300 +15%
Northern Trust
17
Northern Trust
Illinois
$1.65M -$36.9K -11,060 -2%
Goldman Sachs
18
Goldman Sachs
New York
$1.54M +$917K +274,984 +163%
JGC
19
J. Goldman & Co
New York
$1.53M +$1.46M +438,442 New
Morgan Stanley
20
Morgan Stanley
New York
$1.09M -$43.8K -13,123 -4%
Renaissance Technologies
21
Renaissance Technologies
New York
$1.01M +$155K +46,600 +19%
BIP
22
Bouvel Investment Partners
Pennsylvania
$943K +$6.53K +1,958 +0.7%
N
23
Nuveen
North Carolina
$882K +$43.3K +12,990 +5%
DRS
24
Deane Retirement Strategies
Louisiana
$869K -$21.1K -6,316 -2%
QOP
25
Quinn Opportunity Partners
Virginia
$791K

SRTA Hedge Fund Activity: Q2 2024 in Review

117 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q2 2024, worth a combined $135M — up 26% from $107M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SRTA positions and 18 closed out — a net gain of 3 holders — while 41 added to existing stakes and 33 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $1.52M. The largest seller was Uniplan Investment Counsel, cutting an estimated $2.21M.

  • 117 institutional investors held Strata Critical Medical Inc (SRTA) as of Q2 2024, up from 114 in Q1 2024.
  • Funds reported $135M of Strata Critical Medical Inc stock for Q2 2024, up 26% quarter-over-quarter.
  • 21 funds opened new Strata Critical Medical Inc positions in Q2 2024 and 18 closed out, a net change of +3 holders.
  • The largest Strata Critical Medical Inc buyer in Q2 2024 was AWM Investment Company, an estimated $1.52M added.
  • The largest Strata Critical Medical Inc seller in Q2 2024 was Uniplan Investment Counsel, an estimated $2.21M sold.

Based on aggregated 13F filings for Q2 2024.